ArticleCell death discovery2026
GPR84 aggravates lung inflammation through activating ZBP1-PANoptosome mediated PANoptosis following IAV infection.
Article in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Influenza virus-induced pneumonia (IVP) is a contagious lung disease marked by severe lung inflammation following viral infection and remains a significant public health concern due to its high mortality rate. G protein-coupled receptor 84 (GPR84) has been implicated in various inflammatory diseases, however, its role in influenza virus-induced lung inflammation remains poorly understood. In this study, using high-throughput screening, we found that Influenza A virus (IAV) infection markedly upregulates the expression of several G protein-coupled receptors, with GPR84 mRNA and protein levels being highly induced in the lungs of animal models during pneumonia. Mechanistically, GPR84 enhances ZBP1-PANoptosome mediated PANoptosis and exacerbates the release of inflammatory chemokines and danger associated molecular patterns (DAMPs). Notably, deletion of GPR84 attenuates influenza virus-induced PANoptosis, indicating that GPR84 participates in regulating lung inflammation and the pathogenesis of pneumonia during influenza infection. Overall, these findings demonstrate that GPR84 plays a central role in influenza virus-induced lung inflammation by promoting PANoptosis and the release of inflammatory mediators. Targeting GPR84 attenuates IAV-induced PANoptosis, highlighting its potential as a therapeutic target to mitigate the pathogenesis of influenza virus-induced pneumonia.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.